N-nitro-l-arginine, a nitric oxide synthase inhibitor, aggravates iminodipropionitrile-induced neurobehavioral and vestibular toxicities in rats

Experimental and Toxicologic Pathology

Volumn 64, Issue 7-8, 2012, Pages 791-796

  Khan, Haseeb Ahmad ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Behavioral toxicity; Dyskinetic syndrome; Iminodipropionitrile; Nitric oxide; Rats; Synthetic nitriles; Vestibular toxicity

Indexed keywords

3,3' IMINODIPROPIONITRILE; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR CHANGE; CELL DEGENERATION; CERVICAL DYSTONIA; CIRCLING BEHAVIOR; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG DOSE COMPARISON; DYSKINESIA; HAIR CELL; HEAD MOVEMENT; HISTOPATHOLOGY; INCIDENCE; MALE; NEUROTOXICITY; NONHUMAN; OTOTOXICITY; RAT; WALKING;

ANIMALS; BEHAVIOR, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ENVIRONMENTAL POLLUTANTS; MALE; NEUROPSYCHOLOGICAL TESTS; NITRIC OXIDE SYNTHASE; NITRILES; NITROARGININE; RATS; RATS, WISTAR; VESTIBULAR DISEASES; VESTIBULE, LABYRINTH;

ANIMALIA; RATTUS; RATTUS NORVEGICUS; RODENTIA;

EID: 84867730740     PISSN: 09402993     EISSN: 16181433     Source Type: Journal    
DOI: 10.1016/j.etp.2011.01.017     Document Type: Article

References (66)

1. Abekawa T., Ohmori T., Koyama T. Effects of nitric oxide synthesis inhibition on methamphetamine-induced dopaminergic and serotonergic neurotoxicity in the rat brain. J Neural Transm Gen Sect 1996, 103:671-680.
2. Araki T., Mizutani H., Matsubara M., Imai Y., Mizugaki M., Itoyama Y. Nitric oxide synthase inhibitors cause motor deficits in mice. Eur Neuropsychopharmacol 2001, 11:125-133.
3. Arenberg J.G., Komjathy D.A., Seidman M.D., Quirk W.S. Local effects of nitric oxide on vestibular blood flow in the Mongolian gerbil. Eur Arch Otorhinolaryngol 1997, 253:367-371.
4. Balbuena E., Llorens J. Behavioral disturbances and sensory pathology following allylnitrile exposure in rats. Brain Res 2001, 904:298-306.
5. Barjavel J.M., Bhargava H.N. Nitric oxide synthase activity in brain regions and spinal cord of mice and rats: kinetic analysis. Pharmacology 1995, 50:168-174.
6. Barthwal M.K., Srivastava N., Dikshit M. Role of nitric oxide in a progressive neurodegeneration model of Parkinson's disease in the rat. Redox Rep 2001, 6:297-302.
7. Bostanci M.O., Baĝirici F. Nitric oxide synthesis inhibition attenuates iron-induced neurotoxicity: a stereological study. Neurotoxicology 2008, 29:130-135.
8. Brechtelsbauer P.B., Nuttall A.L., Miller J.M. Basal nitric oxide production in regulation of cochlear blood flow. Hear Res 1994, 77:38-40.
9. Cadet J.L. Participation of 5-HT2 serotonin receptor in the IDPN-induced dyskinetic syndrome. Exp Neurol 1988, 99:589-593.
10. Cadet J.L., Braun T., Freed W.J. The dopamine D2 antagonist Ro22-1319, inhibits the persistent behavioral syndrome induced by iminodipropionitrile in mice. Exp Neurol 1987, 96:594-600.
11. Can C., Sen S., Boztok N., Tuglular I. Protective effect of oral l-arginine administration on gentamicin-induced renal failure in rats. Eur J Pharmacol 2000, 390:327-334.
12. Crofton K.M., Knight T. Auditory deficits and motor dysfunction following iminodipropionitrile administration in the rat. Neurotoxicol Teratol 1991, 13:575-581.
13. Crofton K.M., Foss J.A., Hass U., Jensen K.F., Levin E.D., Parker S.P. Undertaking positive control studies as part of developmental neurotoxicity testing: a report from the ILSI Research Foundation/Risk Science Institute expert working group on neurodevelopmental endpoints. Neurotoxicol Teratol 2008, 30:266-287.
14. Darvesh A.S., Yamamoto B.K., Gudelsky G.A. Evidence for the involvement of nitric oxide in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in the rat brain. J Pharmacol Exp Ther 2005, 312:694-701.
15. Dawson V.L., Dawson T.M. Nitric oxide actions in neurochemistry. Neurochem Int 1996, 29:97-110.
16. Dawson T.M., Dawson V.L., Snyder S.H. A novel neuronal messenger molecule in bra the free radical nitric oxide. Ann Neurol 1992, 32:297-311.
17. Del Bel E.A., Souza A.S., Guimarães F.S., da-Silva C.A., Nucci-da-Silva L.P. Motor effects of acute and chronic inhibition of nitric oxide synthesis in mice. Psychopharmacology 2002, 161:32-37.
18. Delay J., Pichot P., Thuillier J., Marquiset J.P. Action de l'aminodipropionitrile sur le comportement moteur de la souris blanche. C R Soc Biol 1952, 146:533-534.
19. Deniz E., Colakoglu N., Sari A., Sonmez M.F., Tugrul I., Oktar S., et al. Melatonin attenuates renal ischemia-reperfusion injury in nitric oxide synthase inhibited rats. Acta Histochem 2006, 108:303-309.
20. Denlinger R.H., Anthony D.C., Amarnath K., Amarnath V., Graham D.G. Metabolism of β,β'-iminodipropionitrile and deuteriumsubstituted analogs: potential mechanisms of detoxification and activation. Toxicol Appl Pharmacol 1994, 124:59-66.
21. Diamond B.I., Reyes M.G., Borison R. A new animal model for Tourette syndrome. Adv Neurol 1982, 35:221-225.
22. Diamond B.I., Sethi K., Borison R.C. Serotonin modulation of hyperkinesias and phasic neck dystonia induced by iminodipropionitrile (IDPN) in rats. Neurology 1986, 36(Suppl. 1):341.
23. Dijkhorst-Oei L.T., Koomans H.A. Effects of a nitric oxide synthesis inhibitor on renal sodium handling and diluting capacity in humans. Nephrol Dial Transplant 1998, 13:587-593.
24. Flugel G., Holm S., Flohr H. The biology of nitric oxide: physiological and clinical aspects 1994, 381-387. Portland Press, London. S. Moncada, M. Fellisch, R. Busse, E.A. Higgs (Eds.).
25. Fritschi J.A., Lauterburg T., Burgunder J.M. Expression of neurotransmitter genes in motor regions of the dyskinetic rat after iminodipropionitrile. Neurosci Lett 2003, 347:45-48.
26. Fukumura M., Sethi N., Vorhees C.V. Effects of the neurotoxin 3,3'-iminodipropionitrile on acoustic startle and locomotor activity in rats: a comparison of functional observational and automated startle assessment methods. Neurotoxicol Teratol 1998, 20:203-211.
27. Gagnaire F., Marignac B., Bonnet P. Relative neurotoxicological properties of five unsaturated aliphatic nitriles in rats. J Appl Toxicol 1998, 18:25-31.
28. Genter M.B., Deamer N.J., Cao Y., Levi P.E. Effects of P450 inhibition and induction on the olfactory toxicity of β,β'-iminodipropionitrile (IDPN) in the rat. J Biochem Toxicol 1994, 9:31-39.
29. Ghaznavi R., Kadkhodaee M. Comparative effects of selective and non-selective nitric oxide synthase inhibition in gentamicin-induced rat nephrotoxicity. Arch Toxicol 2007, 81:453-457.
30. Gianutsos G., Suzdak P.D. Neurochemical effects of IDPN on the mouse brain. Neurotoxicology 1985, 6:159-164.
31. Gil-Loyzaga P., Vicente-Torres M.A., Garcia-Bonacho M., Esquifino A. Presence of catecholamines and serotonin in the rat vestibule. Brain Res 1997, 746:265-268.
32. Green A.R. 5-HT mediated behavior. Neuropharmacology 1984, 23:1521-1528.
33. Harper A., Blythe W.R., Zdanski C.J., Prazma J., Pillsbury H.C. Nitric oxide in the rat vestibular system. Otolaryngol Head Neck Surg 1994, 111:430-438.
34. Hozawa K., Takasaka T. Catecholaminergic innervation in the vestibular labyrinth and vestibular nucleus of guinea pigs. Acta Otolaryngol Suppl 1993, 503:111-113.
35. Ikeda H., Tsuruya K., Toyonaga J., Masutani K., Hayashida H., Hirakata H., et al. Spironolactone suppresses inflammation and prevents l-NAME-induced renal injury in rats. Kidney Int 2009, 75:147-155.
36. Jacobson A.R., Coffin S.H., Shearson C.M., Sayre L.M. β,β'-Iminodipropionitrile (IDPN)-neurotoxicity: a mechanistic hypothesis for toxic activation. Mol Toxicol 1987, 1:17-34.
37. Khan H.A., Al Deeb S., Al Moutaery K., Tariq M. Influence of age on iminodipropionitrile-induced vestibular and neurobehavioral toxicities in rats. Exp Toxicol Pathol 2003, 55:181-186.
38. Khan H.A., Al Deeb S., Al Moutaery K., Tariq M. Metoclopramide attenuates iminodipropionitrile-induced oxidative stress and neurobehavioral toxicity in rats. Pharmacol Biochem Behav 2004, 79:555-561.
39. Khan H.A., Alhomdia A.S., Arif I.A. Neurovestibular toxicities of acrylonitrile and iminodipropionitrile in rats: a comparative evaluation of putative mechanisms and target sites. Toxicol Sci 2009, 109:124-131.
40. Kiss J.P., Zsilla G., Vizi E.S. Inhibitory effect of nitric oxide on dopamine transporters: interneuronal communication without receptors. Neurochem Int 2004, 45:485-489.
41. Kitahara T., Takeda N., Emson P.C., Kubo T., Kiyama H. Change in nitric oxide synthase-like immunoreactivities in unipolar brush cells in the rat cerebellar flocculus after unilateral labyrinthectomy. Brain Res 1997, 765:1-6.
42. Llorens J., Crofton K.M. Enhanced neurotoxicity of 3,3'-iminodipropionitrile following carbon tetrachloride pretreatment in the rat. Neurotoxicology 1991, 12:583-594.
43. Llorens J., Dememes D., Sans A. The behavioral syndrome caused by 3,3'-iminodipropionitrile and related nitriles in the rat is associated with degeneration of the vestibular sensory hair cells. Toxicol Appl Pharmacol 1993, 123:199-210.
44. Mallozzi C., Martire A., Domenici M.R., Metere A., Popoli P., Di Stasi A.M. l-NAME reverses quinolinic acid-induced toxicity in rat corticostriatal slices: involvement of src family kinases. J Neurosci Res 2007, 85:2770-2777.
45. Nace C.G., Genter M.B., Sayre L.M., Crofton K.M. Effect of methimazole, an FMO substrate and competitive inhibitor on the neurotoxicity of 3,3'-iminodipropionitrile in male rats. Fundam Appl Toxicol 1997, 37:131-140.
46. Ogawa N., Mizukawa K., Haba K., Sato H. Neurotransmitter and receptor alterations in the rat persistent dyskinesia model induced by iminodipropionitrile. Eur Neurol 1990, 30:31-40.
47. Padovan-Neto F.E., Echeverry M.B., Tumas V., Del-Bel E.A. Nitric oxide synthase inhibition attenuates l-DOPA-induced dyskinesias in a rodent model of Parkinson's disease. Neuroscience 2009, 159:927-935.
48. Rawls S.M., Jacobs K., Tallarida R.J. Baclofen and NOS inhibitors interact to evoke synergistic hypothermia in rats. Life Sci 2006, 78:669-672.
49. Schulze G.E., Boysen B.G. A neurotoxicity screening battery for use in safety evaluation: effects of acrylamide and 3,3'-iminodipropionitrile. Fundam Appl Toxicol 1991, 16:602-615.
50. Seoane A., Demêmes D., Llorens J. Relationship between insult intensity and mode of hair cell loss in the vestibular system of rats exposed to 3,3'-iminodipropionitrile. J Comp Neurol 2001, 439:385-399.
51. Shi B., Heavner J.E. Nitric oxide modulation affects the tissue distribution and toxicity of bupivacaine. Pharmacol Biochem Behav 2000, 66:623-629.
52. Snyder S.H. Nitric oxide: first in a new class of neurotransmitters. Science 1992, 257:494-496.
53. Stagliano N.E., Dietrich W.D., Prado R., Green E.J., Busto R. The role of nitric oxide in the pathophysiology of thromboembolic stroke in the rat. Brain Res 1997, 759:32-40.
54. 3-induced toxicity in the rat forebrain cortex. J Vet Sci 2009, 10:15-22.
55. Tanii H., Hayashi M., Hashimoto K. Behavioral syndrome induced by allylnitrile, crotonitrile or 2-pentenenitrile in rats. Neuropharmacology 1991, 90:887-892.
56. Tariq M., Al Deeb S., Al Moutaery K., Khan H.A. Cysteamine attenuates iminodipropionitrile (IDPN) induced dyskinesia in rats. Int J Neurosci 1995, 83:165-175.
57. Tariq M., Al Deeb S., Al Moutaery K., Bruyn G.W., Price Evans D., Arshaduddin M. Dipyridamole attenuates the development of iminodipropionitrile-induced dyskinetic abnormalities in rats. Brain Res Bull 1995, 38:31-35.
58. Tariq M., Khan H.A., Al Deeb, Al Moutaery K. Nirtic oxide synthase inhibitor aminoguanidine potentiates iminodipropionitrile induced neurotoxicity in rats. Neurosci Lett 1999, 276:49-52.
59. U.S. Environmental Protection Agency Revised neurotoxicity testing guidelines 1991, NTIS (National Technical Information Services, Publication No. PB 91-154617), Springfield, VA.
60. Urbańska E.M., Drelewska E., Borowicz K.K., Błaszczak P., Kleinrok Z., Czuczwar S.J. NG-nitro-l-arginine, a nitric oxide synthase inhibitor, and seizure susceptibility in four seizure models in mice. J Neural Transm 1996, 103:1145-1152.
61. Vassiljev V., Kalda A., Pokk P., Vali M., Zharkovsky A. The effects of the nitric oxide synthase inhibitor 7-nitroindazole on ethanol pharmacokinetics in rats after acute and chronic ethanol administration. Alcohol Alcohol 1998, 33:609-615.
62. Williams S., Brownlow E.K., Heath H. Studies on the metabolism of beta, beta'-iminodipropionitrile in the rat. Biochem Pharmacol 1970, 19:2277-2287.
63. Zarrindast M.R., Nojoomi K., Sharifzadeh M., Mokri A. Nitric oxide agents and apomorphine-induced rat behaviors. Pharmacology 2004, 71:169-173.
64. Zdanski C.J., Prazma J., Petrusz P., Grossman G., Raymor E., Smith T.L., et al. Nitric oxide synthase is an active enzyme in the spiral ganglion cells of the rat cochlea. Hear Res 1994, 79:39-47.
65. Zhang F., Iadecola C. Nitroprusside improves blood flow and reduces brain damage after focal ischemia. Neuroreport 1993, 4:559-562.
66. Zou J.Y., Martinez D.B., Neafsey E.J., Collins M.A. Binge ethanol-induced brain damage in rats: effect of inhibitors of nitric oxide synthase. Alcohol Clin Exp Res 1996, 20:1406-1411.